Lung cancer: why old smoking patterns still resonate
A Swiss long-term analysis shows that falling lung cancer mortality follows the smoking habits of generations — for women with a clear time lag.
Switzerland is seeing two developments in lung cancer that run at different times. Among men, mortality has been declining for a long time. Among women it stayed high until recently and might only fall markedly in the coming years. That is what a new analysis of Swiss death data since 1969 shows. Its most important finding is not spectacular, but it is central to health policy: lung cancer follows the smoking behaviour of birth cohorts with a large delay.
What the analysis actually shows
The researchers Matthias Lorez, Ben D. Spycher and Christian Schindler analysed cause-of-death data from the Federal Statistical Office from 1969 to 2021. Using an age-period-cohort model, they separated three effects: rising disease risk with age, changes in a particular calendar period, and differences between generations. The model thus makes it possible to read mortality trends not merely as a yearly curve.
Among men, the highest cohort-specific risk in the published results was for birth years around 1909. For men aged 65 to 69, the death rate fell from 330 per 100,000 person-years in the 1970s to 131 in the years 2019 to 2021. Among women, the authors observed the peak at markedly younger birth years, around 1954. In the same age group, the rate rose from 20 to 86 per 100,000 person-years.
This is not a statement about a single grandmother or grandfather. The study does not link individual smoking biographies to deaths. Rather, it shows a population-level association that fits historical differences in tobacco consumption: men started smoking earlier and in greater numbers; among women, the spread began later.
Why medicine alone cannot explain the progress
Better diagnostics and therapies influence survival chances, but they do not fully explain the gender difference. The analysis suggests that cohort effects are especially strong. That means anyone reading today's death figures largely sees the consequences of earlier exposure. The authors predict a decline in absolute deaths among men from the mid-2020s; among women they expect the turning point later. Such projections are not certainties. They rest on extrapolating observed patterns and can be overtaken by changes in smoking, early detection or treatment.
For care, the time lag is still relevant. Oncology services, smoking-cessation counselling and communication about symptoms must reach both sexes. The decline among men does not mean that the overall burden will disappear quickly.
Prevention remains a bet on the future
With the Tobacco Products Act and cantonal prevention programmes, Switzerland has instruments against consumption. Their success in lung cancer, however, only becomes visible with a delay. That is precisely the political challenge: prevention is easily measured by short-term indicators, while its health payoff often only becomes apparent decades later.
The study also has limits. Cause-of-death statistics record mortality, not new cases. No individual blame can be derived from the model, nor an exact number of future deaths prevented. One finding remains solid nonetheless: tobacco smoke is an established cause of lung cancer, and the population does not bear the consequences at the same rhythm.
For the average Swiss man and woman, this is a sobering reminder of the long reach of prevention. Protecting children and young people today from tobacco marketing, access to smoking cessation and reliable cancer care will not decide the statistics of the next quarter. They shape the health balance of the next generations.
